CLINICAL_TRIALS
trial_result
· 2022-04-08
Clinical Trial Update: Study of Hesperidin Therapy on COVID-19 Symptoms (HESPERIDIN) [Phase 2]
Summary
Phase 2 trial evaluating hesperidin therapy for COVID-19–related symptoms has completed; results posted in 2022.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Montreal Heart Institute | Conditions: Covid19, Anosmia | Phase 2 | Status: COMPLETED | Results posted: 2022-04-08